[Continuous hemofiltration and continuous hemodialysis filtration].
Takemoto
Yoshiaki
Y
Department of Urology, Osaka City University Medical School.
Tsuchida
Kenji
K
Kuratsukuri
Katsuyuki
K
D003404:Creatinine / Q000302:isolation & purification; D016207:Cytokines / Q000302:isolation & purification; D015314:Dialysis Solutions / Q000008:administration & dosage; D006333:Heart Failure / Q000150:complications; D017583:Hemodiafiltration / Q000379:methods*; D006440:Hemofiltration / Q000379:methods*; D006801:Humans; D018836:Inflammation Mediators / Q000302:isolation & purification; D051437:Renal Insufficiency / Q000209:etiology / Q000628:therapy; D018746:Systemic Inflammatory Response Syndrome / Q000628:therapy; D014508:Urea / Q000302:isolation & purification; D001613:beta 2-Microglobulin / Q000302:isolation & purification
D016207:Cytokines; D015314:Dialysis Solutions; D018836:Inflammation Mediators; D001613:beta 2-Microglobulin; D014508:Urea; D003404:Creatinine